Key Developments: Heska Corp (HSKA.OQ)

HSKA.OQ on NASDAQ Stock Exchange Capital Market

13.00USD
29 Sep 2014
Price Change (% chg)

$-0.22 (-1.66%)
Prev Close
$13.22
Open
$13.41
Day's High
$13.41
Day's Low
$12.78
Volume
21,915
Avg. Vol
9,094
52-wk High
$14.56
52-wk Low
$5.59

Search Stocks

Latest Key Developments (Source: Significant Developments)

Heska Corp Announces Sale Of Non-Core Assets To Eli Lilly and Co's Division
Monday, 24 Jun 2013 09:00am EDT 

Heska Corp announced the sale of certain non-core assets useful for the production of both bovine and feline vaccines to Elanco Animal Health, a division of Eli Lilly and Co. Heska does not anticipate any change in its current bovine and feline vaccine production at its wholly-owned facility in Des Moines, Iowa as a result of the agreement with Elanco. Financial terms were not disclosed.  Full Article

Heska Corp Announces Appointment Of President-Form 8-K
Tuesday, 26 Feb 2013 10:31pm EST 

Heska Corp reported in its Form 8-K that on February 24, 2013, the Board of Directors of the Company appointed Kevin S. Wilson, as the Company‚Äôs President and Chief Operating Officer.  Full Article

Heska Corp suspends Quarterly Dividend
Monday, 25 Feb 2013 04:00pm EST 

Heska Corp announced that Following the acquisition of a majority interest in Cuattro Vet, the Company also formally announced that its Board of Directors has decided to suspend the Company's quarterly dividend for the foreseeable future. When making this decision, the Board considered the cash likely to be required to purchase the remaining 45.4% of Cuattro Vet, the cash required to complete the purchase of 54.6% of Cuattro Vet and other acquisitions the Company is considering. The Company expects it will be able to generate enhanced shareholder value by investing in the growth of its business, including through attractive acquisitions, rather than distributing cash dividends.  Full Article

Heska Corp Acquires Majority Interest In Cuattro Veterinary USA
Monday, 25 Feb 2013 07:00am EST 

Heska Corp announced the acquisition of 54.6% of Cuattro Veterinary USA, LLC. The Company will continue to use the Cuattro name, brands, R&D, sales, service and production resources that have made Cuattro Vet, digital radiography, cloud-based PACS, ultrasound and imaging services suite in veterinary medicine. Terms of the transaction were not disclosed.  Full Article

Search Stocks